UnknownNot Applicable

Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC

China500 participantsStarted 2021-01-01

Plain-language summary

Currently, there are few studies on the diagnostic ability of CEUS-LI-RADS in patients with non-high risk factors for liver nodules. Whether this classification is applicable to such patients remains controversial. There are relatively few studies on the diagnostic efficacy of HCC in clinical diagnosis and the consistency between map readers, and the applicable population is only focused on patients with hepatic fibrosis. Therefore, this study explored the application value of CEUS Li-RADS in liver focal lesions in patients with non-high risk factors for hepatocellular carcinoma.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient showed focal liver lesions on routine ultrasound examination. * Non-HCC high-risk patients (hepatitis B, cirrhosis) Exclusion Criteria: * High-risk patients with HCC (hepatitis B, cirrhosis); * Patients with solid liver tumors could not be found by conventional imaging; * Patients who do not sign informed consent;

What they're measuring

Positive Predictive Value

Timeframe: 3 years

Negative Predictive Value

Timeframe: 3 years

Sensitivity

Timeframe: 3 years

Specificity

Timeframe: 3 years

Trial details

NCT IDNCT04920214

SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12-31

Contact for this trial

Pintong Huang

+8618857168333 huangpintong@126.com

View on ClinicalTrials.gov More Hepatocellular Carcinoma trials